Zanosar (Streptozocin Vials) 1g

Zanosar (streptozocin) is a chemotherapy medication supplied as 1g vials for injection. It is used in the treatment of pancreatic cancer and other conditions requiring cytotoxic therapy. Store between 2-8°C and protect from light. Consult a healthcare professional for suitability.

Strength

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Esteve Pharmaceuticals GmbH

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Streptozocin, the active ingredient in Zanosar, is primarily used to treat pancreatic cancer, including metastatic islet cell carcinoma. It may also be used in other cancer treatments where cytotoxic therapy is indicated. This medication works by interfering with the growth of cancer cells. Patients often ask, 'what is streptozocin used for' in relation to pancreatic cancer management.

Side Effects

As a chemotherapy agent, Zanosar may cause effects such as nausea, vomiting, or fatigue during treatment. Some patients report changes in kidney function or blood counts, which are monitored by healthcare providers. These effects vary by individual and treatment protocol. Always discuss concerns with a medical professional.

Precautions & Warnings

Zanosar should be handled with care, using protective equipment due to its cytotoxic nature. It must be stored refrigerated between 2-8°C and protected from light. Avoid exposure if pregnant or breastfeeding. Keep out of reach of children and pets. Dispose of unused medication properly.

Avoid Interactions

Zanosar may interact with other medications affecting kidney function or blood counts, such as certain antibiotics or diuretics. Alcohol and other chemotherapy drugs may increase side effects. Always inform your healthcare provider about all medications and supplements you are taking. Some interactions can amplify toxicity.

Frequently Asked Questions

Zanosar is used to treat pancreatic cancer and other conditions requiring cytotoxic therapy, as prescribed by a healthcare professional.

Zanosar is administered by injection, typically in a clinical setting by trained medical staff.

Common side effects may include nausea, vomiting, fatigue, or changes in kidney function, which should be monitored.

Zanosar is a prescription medication and should only be obtained through licensed pharmacies with a valid prescription.

Zanosar should be stored refrigerated between 2-8°C and protected from light.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.